PPA
IRMD icon

Parametric Portfolio Associates’s iRadimed IRMD Stock Holding History

Parametric Portfolio Associates’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.47M Sell
32,866
-3,346
-9% -$155K ﹤0.01% 2577
2021
Q4 		$1.67M Sell
36,212
-15,884
-30% -$641K ﹤0.01% 2552
2021
Q3 		$1.75M Sell
52,096
-6,832
-12% -$232K ﹤0.01% 2512
2021
Q2 		$1.73M Buy
58,928
+32,585
+124% +$898K ﹤0.01% 2515
2021
Q1 		$679K Buy
+26,343
New +$629K ﹤0.01% 3344

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RCG
Resource Consulting Group Orlando, Florida $584M AUM 15.38% 1-Year Est. Return

Parametric Portfolio Associates's IRMD Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its iRadimed (IRMD) stake by 9.2% in Q1 2022, selling an estimated $155K and leaving 32,866 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

Parametric Portfolio Associates first reported a position in IRMD in Q1 2021 and has held it in 5 quarters since. The position peaked at $1.75M in Q3 2021. 104 funds tracked by Wall St. Rank hold IRMD as of Q1 2022.

  • Parametric Portfolio Associates held 32,866 shares of iRadimed worth $1.47M as of Q1 2022.
  • Parametric Portfolio Associates sold 3,346 iRadimed shares in Q1 2022, an estimated $155K.
  • iRadimed made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2577 holding.
  • Parametric Portfolio Associates first reported a position in iRadimed in Q1 2021 and has held it in 5 quarters since.
  • Parametric Portfolio Associates's iRadimed position peaked at $1.75M in Q3 2021.
  • 104 funds tracked by Wall St. Rank held iRadimed as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.